INTRODUCTION
There is considerable evidence in experimental animals to indicate that immunoglobulin (Ig) E synthesis by B lymphocytes is regulated by both helper and suppressor T lymphocytes (1) (2) (3) (4) (5) (6) (7) (8) . Much less is known about the regulation of IgE synthesis in man. Studies from several laboratories indicate that peripheral blood lymphocytes (PBL) from atopic patients synthesize large amounts of IgE spontaneously in vitro, whereas normal PBL fail to do so (9) (10) (11) (12) . The basis for this difference is not completely clear but has important implications for the understanding of the human reaginic response and the potential manipulation of this response. Studies by Fiser and Buckley (12) and Saxon and co-workers (13) have indicated that in many instances, normal T lymphocytes are capable of suppressing IgE synthesis when co-cultured with lymphocytes from atopic patients and suggested that IgE-specific suppressor T cells may be deficient in hyper IgE states. In a recent study, patients with the hyper IgE syndrome were shown to be deficient in circulating T8+ cells, a subset that in normal subjects was responsible for the suppression of IgE synthesis (14) .
Increased IgE synthesis may result not only from a deficiency of IgE-specific suppressor T cells but also from increased IgE-specific helper T cells. In the present work we examined the regulation of IgE synthesis in patients with acute graft vs. host disease (GVHD)' after transplantation of allogeneic bone marrow. Our experience has indicated that these patients frequently exhibit elevated levels of serum IgE (15) . The data presented here suggest that a deficiency in IgE-specific suppressor cells as well as activation of IgE-specific T helper cells underlie the increased production of IgE in patients with acute GVHD.
METHODS
Subjects. Eight patients undergoing bone marrow transplantation (BMT) were studied. The clinical characteristics of these patients are shown in Table I . All eight patients received allogeneic bone marrow from HLA-A, B, C, and D histocompatible siblings. Patients transplanted for leukemia were prepared with cytosine arabinoside, cyclophosphamide (CTX), and total body irradiation (800 rad). The patient with aplastic anemia and the patient with paroxysmal nocturnal hemoglobinuria were prepared with rabbit antithymocyte serum, procarbazine, and CTX. The patient with Wiskott-Aldrich syndrome was prepared with antithymocyte serum, CTX, and busulfan. Patients were maintained in protective isolation, received a diet low in bacterial content, and were administered nonabsorbable oral antibiotics. Six patients (1) (2) (3) (4) 6 , and 8) received methotrexate, 10 mg/m2, as prophylaxis against acute GVHD on days 1, 3, and 11. The remaining two patients (5 and 7), whose donors were identical twins, did not receive methotrexate.
Normal subjects, whose serum IgE levels were <100 IU/ ml, were used as a source of normal PBL in co-culture experiments. Written consent was obtained from all subjects after the purposes of the study were explained to them.
Scoring of acute GVHD. The diagnosis of GVHD was made clinically by the characteristic skin rash substantiated by skin biopsy, elevation of hepatocellular enzymes, and diarrhea. The severity of the GVHD was scored by the Seattle criteria (16 (14) . The wells were filled with 0.1 ml of a 0. (14) . First, it was determined that 0.1 ml of a 1:1,000 dilution of a gamma chain-specific rabbit anti-human IgG (N. L. Cappel Laboratories, Inc. Cochranville, PA) precipitated 70% of the radioactivity from 10 ng of '251-labeled human IgG (3,000 cpm/ng). Subsequently, 0.1 ml of culture supernate (or of its dilutions) or of standard IgG solutions was added to 0.1 ml of 1:1,000 rabbit antiserum in a Beckman plastic microfuge tube (Beckman Instruments, Inc., Fullerton, CA). After an incubation of 1 h at 370C, 10 ng '25I-IgG were added. The tubes were incubated for 1 h at 370C, then normal rabbit serum and goat anti-rabbit IgG (preabsorbed against Sepharose-bound human IgG) were added at equivalence. After a 1-h incubation at 370C and an overnight incubation at 40C, the immune precipitates were washed three times in ice-cold PBS in a Beckman microfuge, and counted in a Tracor Analytic gamma spectrometer. IgG present in an individual culture supernate was read from the standard curve. The specificity of the assay for human IgG was demonstrated by the failure of large excesses of myeloma IgM, human IgA, or of K and L chains to inhibit the binding of '25I-IgG to rabbit anti-IgG.
Enumeration of T cells and T cell subsets. Monoclonal antibodies reactive with the T cell surface antigens T3, T4, and T8 were purchased from Ortho Diagnostics (Raritan, NJ). These antibodies have been previously shown to be restricted in their reactivity to cells of T cell lineage (17, 18) . Anti-T3 reacts with 90% of E-rosette-positive peripheral T cells and 10% of thymocytes. In contrast, anti-T4 and anti-T8 react with the majority of thymocytes and with 60 and 30% of peripheral T cells, respectively. Functionally, anti-T4 defined the human inducer (helper) T cell subset, whereas anti-T8 defined the human suppressor/cytotoxic population (17, 18) .
Immunofluorescent analysis of unfractionated cell populations was performed by indirect immunofluorescence with fluorescein-conjugated goat anti-mouse IgG (G/M FITC, N. L. Cappel Laboratories, as previously described) (19) . Fluorescent cells were counted by using a Zeiss fluorescent microscope (Carl Zeiss, Inc., New York, NY). A minimum of 200 cells were counted. Background fluorescence reactivity was determined with a control mouse ascites and never exceeded 3%. All analyses were performed without knowledge of the patient's clinical status.
Effect of allogeneic cells on in vitro synthesis of IgE by the patient's PBL. In these experiments, 1 million normal allogeneic PBL, T cells, and T cells depleted of either T4+ or T8+ cells were mixed with 1 million PBL from the patients and cultured in a final volume of 1 ml/culture. The value of IgE observed in the supernatants of the mixed cell culture was compared with the expected value of IgE, which was calculated to be the sum of the IgE synthesized in individual cultures of the patient's PBL (1 X 106 cells in 1 ml) and of allogeneic cells (1 X 106 cells in 1 ml) . The assumption that the expected amount of IgE in co-cultures should equal the sum of IgE present in the individual cultures was verified previously by showing that the amount of IgE present in the supernatant of a 1-ml culture containing 2 X 106 cells/ml was approximately twice the amount of IgE present in the supernatant of a 1-ml culture containing 1 X 106 cells/ml.
Percentage of suppression of IgE synthesis by normal cells was calculated as: 1 -(observed value of IgE/expected value of IgE) X 100.
Complement-dependent lysis of T cell subsets. This was performed as previously described (14) . Briefly, 20 million T lymphocytes were suspended in 0.8 ml of a 1:250 dilution of anti-T8 or anti-T4 in PBS and incubated for 1 h at room temperature. 0.2 ml rabbit serum (Pel-Freeze Biologicals, Inc., Rogers, AR) was then added and the suspension was incubated an additional 60 (16) . None of the patients had a previous history of allergic disorders. Serum IgE levels were normal in five patients before BMT, moderately elevated in one patient (5) , and borderline high in two patients (1, 8) .
Serum IgE levels rose in all seven patients with acute GVHD but not in the patient without acute GVHD. Serum IgE started to rise beginning day 14 to day 28 after BMT, peaked between days 20 and 40 postBMT, and in six of the seven patients returned to within normal range by 12 wk posttransplant. Fig. 1 illustrates the time course of the rise and fall of serum IgE levels in two patients (1 and 5) and its relationship to acute GVHD.
Serum IgE levels in the BMT donors were <200 IU/ ml in all cases except one, the donor for patient 4, whose serum IgE was 475 IU/ml.
In vitro synthesis of IgE. The spontaneous secretion of de novo-made IgE in 7-d cultures of unfractionated PBL from the patients and from six nonallergic healthy subjects is shown in Table II . PBL were obtained from patients within a few days of the time at which their serum IgE levels peaked and 4 wk posttransplant from patient 8. Net IgE synthesis by PBL obtained from seven patients during acute GVHD was markedly increased and averaged 17,923±14,607 pg/ 106 cells (Table II) . PBL from the patient without GVHD synthesized negligible amounts of IgE in vitro (Table II) . PBL from five of six normal controls made either no detectable IgE (five of six cases) or negligible amounts of IgE (Table II) . In contrast to the increased spontaneous synthesis of IgE by PBL observed during acute GVHD, there was no concomittant increase in the spontaneous secretion of IgG compared with normal controls (404±78 ng of IgG/106 cells for normal PBL, n = 6, vs. 460±81 ng of IgG/106 cells for patient's PBL in acute GVHD, n = 4). Negligible amounts of de novo IgE were made by PBL from three patients (1, 4, and 6) studied before BMT (66±69 pg/106 cells). PBL from five patients were studied after the resolution of the acute GVHD and the return of serum IgE towards normal and were found to secrete negligible amounts of IgE (106±31 pg/106 cells).
Suppression of IgE synthesis by normal PBL and by PBL obtained after the resolution of acute GVHD. The production of human IgE in vitro has been shown to be regulated by normal circulating suppressor cells (14) . We therefore performed a series of mixing ex- Cells from a single subject were frozen at different intervals and then used for different experiments. 4 The allogeneic subject used in this experiment is subject 7. § The allogeneic subject with acute GVHD used in this experiment is not shown in Table I and his PBL were taken when his serum IgE was elevated; 7,500 IU/ml. of the large number of T cells required to generate the supernatants and because of the lymphopenia of the patients during acute GVHD, these experiments were performed in two patients only (6 and 7). Control supernatants were generated from normal T cells including the T cells from the normal bone marrow donor, in one case (7) . Normal B cells were derived from unrelated adult nonallergic subjects whose PBL made 100 pg/106 cells in culture. As shown in Table V Relationship between acute GVHD, cytotoxic regimen used for recipient preparation, and elevated serum IgE. Because administration of cytotoxic drugs in experimental animals can result in the enhancement of IgE synthesis (20, 21) it was necessary to examine the relationship of the cytotoxic drug regimen administered to the patients before BMT and acute GVHD No IgE could be measured (<100 pg/ml) in supernatants of the unstimulated normal B cells used in these experiments.
I Addition of cycloheximide to normal B cell cultures reduced the IgG measured in the supernatants to <50 ng/ml.
Und, Undetectable.
Human Immunoglobulin E Synthesis in Acute Graft vs. Host Disease (Table I ). The eighth patient had no acute GVHD and her serum IgE levels did not rise. Because of the lack of allotypic markers on the IgE molecule, it is not known whether the elevated IgE is of donor or recipient origin or both.
In comparison with normals, PBL from patients with acute GVHD spontaneously secreted large quantities of IgE in vitro (Table II) . IgE synthesis in our patients was suppressed by normal lymphocytes but not by lymphocytes obtained during acute GVHD (Table III) . More importantly, cells obtained after the resolution of the acute GVHD, and the return of serum IgE to normal, suppressed IgE synthesis of autologous cells collected during acute GVHD (Table III) , suggesting that IgE-specific suppressor cells were relatively deficient during acute GVHD, i.e., not sufficient to oppose IgE-specific T cell help. Normal IgE suppressor cells have been shown to bear the T8 antigen (14) . However, despite their deficiency in IgE suppressor cells, patients with acute GVHD were found to have normal or increased percentages of T8+ cells (Table   IV) (23, 24) . It is possible that whole-body irradiation, CTX, or other chemotherapeutic agents could cause transient thymic dysfunction. Reconstitution of thymic function could result in the gradual reestablishment of functional suppressor cells, which could then abrogate IgE synthesis, as indeed occurred in our patients. Alternatively it is possible that concomittant infection of our patients by ubiquitous organisms such as cytomegalovirus (25) may have contributed to the T cell subset imbalance seen.
In light of the severe depression in suppressor T cell function in acute GVHD, the selective elevation of the IgE isotype was thought to reflect the in vivo presence of activated IgE-specific helper cells. In this regard, activated T cells expressing Ia antigens have been shown to be present in the circulation in acute GVHD (26) . Circulating activated IgE-specific helper T cells were clearly demonstrated in acute GVHD because freshly isolated T cells from the patients spontaneously released in vitro an IgE-specific helper factor (Table  V) . Although T cells from only two patients were studied for their capacity to release an IgE helper factor, a similar factor has been identified recently by us in supernatants of T cells obtained from patients with the hyper-IgE syndrome and from patients with atopic dermatitis and elevated serum IgE levels (27) . Previous attempts by several investigators (12, 13) at demonstrating induction of IgE synthesis in normal B cells by T cells from atopic patients have generally met with failure. This may have been due to several factors such as differences in the source of the T cells, use of relatively low number of T cells, and the possible induction of suppressor effects in a mixed lymphocyte culture.
The selectivity of the T cell-derived helper factor in inducing IgE but not IgG synthesis in normal B cells suggests that the conditions and/or the T cells required to generate IgE-specific help in man may differ from those required to generate IgG-specific help. Indeed, had IgG-specific helper T cells been activated in our patients, then elevated IgG levels in vivo and elevated IgG synthesis in vitro should have been observed. Clearly, this was not the case. Actually, serum IgG levels steadily fell in our patients after their preparation for BMT and remained low for a few months afterwards. Prolonged depression of IgG synthesis in vivo and in vitro after BMT has been well documented by Ringden et al. (28) .
IgE-specific helper factors have been shown to exist in experimental animal systems where IgE and IgG synthesis can be differentially controlled by immunoregulatory T cells (6). Ishizaka and co-workers (29) have described the spontaneous release of an IgE-specific helper factor by T lymphocytes isolated from the lymph nodes of rats infected with Nippostrongylus braziliensis. This IgE potentiating factor had affinity for IgE and could also be detected by its ability to inhibit rosette formation of Fc receptor-bearing cells with IgE-coated erythrocytes. We are currently attempting to define the characteristics of the human IgE helper factors.
In our experience, serum IgE elevation in BMT has not occurred in the absence of acute GVHD (Table  VI) . It 
